Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.

To put data from our recent systematic review of phase 3 studies of anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies into the context of clinical practice.